[Crigler-Naijar syndrome. Clinical, biochemical, morphologic and therapeutic aspects].
D001646:Bile / Q000032:analysis; D001663:Bilirubin / Q000032:analysis / Q000097:blood; D002855:Chromatography, Thin Layer; D004796:Clinical Enzyme Tests; D005260:Female; D005965:Glucuronates; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology / Q000532:radiotherapy; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis*; D008099:Liver / Q000032:analysis / Q000473:pathology; D010634:Phenobarbital / Q000627:therapeutic use; D014166:Transferases / Q000097:blood; D014467:Ultraviolet Therapy
D005965:Glucuronates; D014166:Transferases; D001663:Bilirubin; D010634:Phenobarbital
Das Crigler-Najjar-Syndrom. Klinische, biochemische, morphologische und therapeutische Aspekte.